Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 08, 2011

Long-Term Response to Lenalidomide Possible in Multiple Myeloma

Leukemia and Lymphoma

 

Additional Info

Leukemia and Lymphoma
Lenalidomide Can Induce Long-Term Responses in Patients With Multiple Myeloma Relapsing After Multiple Chemotherapy Lines, In Particular After Allogeneic Transplant
Leukemia and Lymphoma 2011 Jul 01;52(7)1262-1270, F Spina, V Montefusco, C Crippa, A Citro, S Sammassimo, B Olivero, S Gentili, M Galli, T Guglielmelli, D Rossi, A Pia Falcone, M Grasso, F Patriarca, M De Muro, P Corradini

Further Reading